1, 2025, 3:03 PM UTC Eli Lilly & Co
What happens if I cannot tolerate the side effects
GLP-1 microdosing may appeal to people who are interested in metabolic support but are cautious about traditional higher-dose protocols
"With the positive results across five Phase 3 studies, we now have the clinical data package to support global submissions for retatrutide and look forward to working with regulators as they evaluate this first-of-its-kind medicine, said Kenneth Custer, Ph.D., executive vice president and president, Lilly Cardiometabolic Health
1 2 3 GHS peptides work differently
Limited research shows that some of the ingredients in these dietary supplements may be helpful for weight loss and lowering blood sugar, but more research is needed to understand their safety and effectiveness